Events - November 2, 2022

Welcome to Our New Office!

We are very excited about opening our new office, and we want to share it with you!

Our new office is in a fantastic location (Westerkade 5A, 3016 CL Rotterdam), providing commanding views of the Nieuwe Maas river. It’s a great place for our team to work and meet with clients, and it will serve as a great launching pad for the next phase of AIM growth. We look forward to many years here!

Renovating this new space took quite a lot of teamwork, and we’re very proud of every member of the AIM team. We hope you’ll enjoy this quick video tour of our new home…

Events - October 20, 2022

Webinar – Supply Chains for Cell & Gene Therapies: Orchestrating a Successful Launch & Beyond


October 20, 2022 – 11:00 am ET

Advanced Therapy Medicinal Products (ATMPs), also known as cell and gene therapies, are becoming increasingly common.  However, they’re far more complex than “traditional” biotech products, with sophisticated requirements throughout their supply chains.  This webinar will:

  • Identify the unique components that make ATMP supply chains so complex
  • Show key points where precise orchestration is needed to prepare supply chains for launch and keep them running smoothly
  • Provide guidance for decision makers, who must orchestrate supply chains in an environment with evolving regulatory frameworks and few consistent standards


Ronald van Zitteren, Principal, AIM


Laurent Goux
Senior Vice President and General Manager, Europe, Krystal Biotech, Inc.

Reinout Hesselink, Ph.D., R.H
Cell Therapy Consulting

David Kann
Senior Associate, AIM

Events - November 15, 2021

Webinar Recording Now Available – Launching a First Product in Europe: The Supply Chain Perspective

On 27 October 2021, AIM hosted a webinar panel discussion in partnership with Fierce Markets, publishers of Fierce Pharma and Fierce Biotech.  The webinar addressed the key supply chain aspects associated with launching a new pharmaceutical or biotech therapy in Europe. 

Our panel of experts included:

  • Pim Van Der Aar, Co-Founder & Managing Director, AIM (Moderator)
  • Christian Ellereit, Head of Finance, Europe, Travere Therapeutics
  • Ronald van Zitteren, Principal, AIM
  • Joop Wijdeven, Associate, AIM

The panelists covered supply chain key success factors, best practices, and common pitfalls and mistakes.  They also discussed key licensing and legal requirements, as well as the main steps involved in designing and implementing a life science supply chain in Europe.  This 59-minute video is a recording of the webinar.

Events - October 27, 2021

Webinar – Launching a First Product in Europe: The Supply Chain Perspective


October 27, 2021 – 11:00 am ET

Creating a flawless and efficient supply chain is fundamental to the success of any first launch in Europe.  Legislation is slowly beginning to harmonize across the EU and service providers are improving their capabilities, but there are still many local factors to consider.  In addition, there are many “moving parts” that are often overlooked until it’s too late.

This webinar will identify and address the critical aspects that companies must consider when creating a distribution and financial infrastructure in Europe.  Our expert panel will share their experiences, as well as discuss the key benchmarks and pitfalls on the journey to building the optimal supply chain infrastructure.


Pim van der Aar, Co-Founder & Managing Director, AIM


Christian Ellereit
Head of Finance, Europe, Travere Therapeutics

Ronald van Zitteren
Principal, AIM

Joop Wijdeven
Associate, AIM